Zymeworks Inc (ZYME)
9.10
-0.28
(-2.99%)
USD |
NASDAQ |
May 17, 16:00
9.10
0.00 (0.00%)
After-Hours: 20:00
Zymeworks Cash from Operations (Quarterly): -37.67M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -37.67M |
| December 31, 2023 | 13.95M |
| September 30, 2023 | -42.67M |
| June 30, 2023 | -6.399M |
| March 31, 2023 | -83.19M |
| December 31, 2022 | 327.36M |
| September 30, 2022 | -73.02M |
| June 30, 2022 | -54.82M |
| March 31, 2022 | -55.41M |
| December 31, 2021 | -50.51M |
| September 30, 2021 | -50.79M |
| June 30, 2021 | -50.35M |
| March 31, 2021 | -40.80M |
| December 31, 2020 | -47.90M |
| September 30, 2020 | -16.06M |
| June 30, 2020 | -49.96M |
| March 31, 2020 | -37.49M |
| Date | Value |
|---|---|
| December 31, 2019 | -36.35M |
| September 30, 2019 | -10.88M |
| June 30, 2019 | -13.32M |
| March 31, 2019 | -21.30M |
| December 31, 2018 | 50.10M |
| September 30, 2018 | -12.82M |
| June 30, 2018 | 4.46M |
| March 31, 2018 | -17.57M |
| December 31, 2017 | 39.02M |
| September 30, 2017 | -12.15M |
| June 30, 2017 | -13.95M |
| March 31, 2017 | -12.70M |
| December 31, 2016 | -8.597M |
| September 30, 2016 | -14.40M |
| June 30, 2016 | -5.274M |
| March 31, 2016 | -6.973M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-83.19M
Minimum
Mar 2023
327.36M
Maximum
Dec 2022
-20.81M
Average
-41.74M
Median
Cash from Operations (Quarterly) Benchmarks
| Emergent BioSolutions Inc | -62.60M |
| MariMed Inc | 3.21M |
| Viemed Healthcare Inc | 1.175M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -7.316M |
| Cash from Financing (Quarterly) | 2.123M |
| Free Cash Flow | -77.13M |
| Free Cash Flow Per Share (Quarterly) | -0.5026 |
| Free Cash Flow to Equity (Quarterly) | -38.32M |
| Free Cash Flow to Firm (Quarterly) | -38.32M |
| Free Cash Flow Yield | -11.87% |